| |
|
12 months ended |
| |
|
31 December |
 |
|
|
|
|
| |
|
2008 |
|
2007 |
| |
|
Unaudited |
|
Unaudited |
| |
|
Rm |
|
Rm |
| COMPARABLE INCOME STATEMENTS |
|
|
|
|
| Revenue |
|
15 209 |
|
11 449 |
| Net operating profit |
|
2 811 |
|
1 640 |
| Net financing costs |
|
(457) |
|
(453) |
| Investment and equity income |
|
1 603 |
|
685 |
| Income tax expense |
|
(546) |
|
(500) |
| Minority interest |
|
24 |
|
(20) |
| Add back items for headline earnings |
|
228 |
|
22 |
| Headline earnings |
|
3 663 |
|
1 374 |
| Headline earnings per share (cents) |
|
1 068 |
|
403 |
| Dividends per share (cents) |
|
375 |
|
160 |
| Average realised exchange rate (R/US$) |
|
8,10 |
|
7,26 |
| COMPARABLE STATEMENTS OF CASH FLOWS |
|
|
|
|
| Cash flows from operating activities |
|
2 131 |
|
1 507 |
| Cash flows from investing activities |
|
(973) |
|
(4 123) |
| Cash flows from financing activities |
|
2 765 |
|
(453) |
| Net increase/(decrease) in cash and cash equivalents |
|
3 923 |
|
(3 069) |
| |
|
At 31 December |
|
|
|
|
|
| |
|
2008 |
|
2007 |
| |
|
Unaudited |
|
Unaudited |
| |
|
Rm |
|
Rm |
| GROUP STATEMENTS OF FINANCIAL POSITION |
|
|
|
|
| Assets |
|
|
|
|
| Non-current assets |
|
|
|
|
| Property, plant and equipment |
|
11 309 |
|
10 343 |
| Biological assets |
|
34 |
|
30 |
| Intangible assets |
|
79 |
|
76 |
| Investments in associates and joint ventures |
|
1 849 |
|
712 |
| Deferred tax |
|
1 083 |
|
732 |
| Financial assets |
|
1 577 |
|
1 046 |
| Current assets |
|
|
|
|
| Cash and cash equivalents |
|
1 769 |
|
850 |
| Inventories, trade and other receivables |
|
5 407 |
|
4 101 |
| Non-current assets classified as held for sale |
|
78 |
|
2 |
| Total assets |
|
23 185 |
|
17 892 |
| Equity and liabilities |
|
|
|
|
| Capital and reserves |
|
|
|
|
| Equity attributable to owners of the parent |
|
12 996 |
|
9 728 |
| Minority interest |
|
128 |
|
19 |
| Total equity |
|
13 124 |
|
9 747 |
| Non-current liabilities |
|
|
|
|
| Interest-bearing borrowings |
|
3 650 |
|
3 798 |
| Non-current provisions |
|
1 746 |
|
1 414 |
| Financial liabilities |
|
31 |
|
|
| Deferred tax |
|
1 257 |
|
1 065 |
| Current liabilities |
|
|
|
|
| Interest-bearing borrowings |
|
500 |
|
74 |
| Other |
|
2 827 |
|
1 794 |
| Non-current liabilities classified as held for sale |
|
50 |
|
|
| Total equity and liabilities |
|
23 185 |
|
17 892 |
| Net debt |
|
2 381 |
|
3 022 |
| ANALYSIS PER SHARE |
|
|
|
|
| Number of shares in issue (million) |
|
355 |
|
353 |
| Weighted average number of shares in issue (million) |
|
343 |
|
341 |
| Earnings per ordinary share |
|
|
|
|
| – Attributable earnings (cents) |
|
1 002 |
|
396 |
| – Headline earnings (cents) |
|
1 068 |
|
403 |
| Dividend declared per ordinary share (cents) |
|
375 |
|
160 |
| Dividend cover (times) |
|
2,67 |
|
2,48 |
| Net asset value per ordinary share (cents) |
|
3 661 |
|
2 756 |
| Attributable cash flow per ordinary share (cents) |
|
681 |
|
440 |
